HomeAbout UsPress Releases (German)NEC Laboratories Europe announces the start of pre-clinical validation studies for NEC’s AI-driven blueprint design for SARS-CoV-2 vaccine
Press Releases (German)
NEC Laboratories Europe announces the start of pre-clinical validation studies for NEC’s AI-driven blueprint design for SARS-CoV-2 vaccine
NEC Laboratories Europe announces the start of pre-clinical validation studies for NEC’s AI-driven blueprint design for SARS-CoV-2 vaccine